← Scoopfeeds — Intelligent news, curated.
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
business

Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M

Yahoo Finance · May 18, 2026, 4:49 AM · Also reported by 4 other sources

Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Earnings call transcript: Arvinas Inc. reports Q1 2026 earnings, stock reacts Investing.com Earnings call transcript: iHeartMedia Q1 2026 reveals mixed results with EPS miss Investing.com Earnings call transcript: BuzzFeed Q1 2026 results show revenue decline Investing.com Earnings call transcript: Harrow Health Q1 2026 results miss expectations

More in business

Investing.com
Kaltura chief customer officer Natan Israeli sells $43,704 of stock
Bloomberg Markets
European Markets Watchdog Shortlists Six Officials for Top Job
Investing.com
Hims & Hers plans $300 million convertible notes offering
Investing.com
Bernstein initiates Basic-Fit at "outperform" with 45% upside target
Investing.com
NextEra Energy announces leadership changes at Florida Power & Light
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop